Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Vice President, Corporate Business Development, Eli Lilly and Company
Travis is currently responsible for leading and managing business development transactions for Eli Lilly’s cardiometabolic disease, drug delivery, and device efforts.
He has had a variety of finance and business development experiences at Lilly, including positions as Finance Director of Lilly’s Oncology Business Unit, Director of Investor Relations, Director of Corporate Finance and Investment Banking, and other financial controllership roles. Travis’ business development experiences have encompassed responsibilities ranging from managing the strategic and economic analyses of transactions to leading contract negotiations to having financial leadership of alliances.
Before transitioning to finance and business development, he was a Chemist in Lilly’s research laboratories and a Production Manager for Milliken & Company.
Travis earned his MBA from the Ross School of Business at the University of Michigan and his B.S. in Chemistry from Rose-Hulman Institute of Technology.